Khanal Sudeepa, Elsey Helen, King Rebecca, Baral Sushil C, Bhatta Bharat Raj, Newell James N
Health Research and Social Development Forum (HERD) Nepal, Thapathali, Kathmandu, Nepal.
Nuffield Centre for International Health and Development (NCIHD), University of Leeds, Charles Thackrah Building, Leeds, United Kingdom.
PLoS One. 2017 Jan 18;12(1):e0167559. doi: 10.1371/journal.pone.0167559. eCollection 2017.
Multi-drug-resistant tuberculosis (MDR-TB) poses a major threat to public health worldwide, particularly in low-income countries. The current long (20 month) and arduous treatment regime uses powerful drugs with side-effects that include mental ill-health. It has a high loss-to-follow-up (25%) and higher case fatality and lower cure-rates than those with drug sensitive tuberculosis (TB). While some national TB programmes provide small financial allowances to patients, other aspects of psychosocial ill-health, including iatrogenic ones, are not routinely assessed or addressed. We aimed to develop an intervention to improve psycho-social well-being for MDR-TB patients in Nepal. To do this we conducted qualitative work with MDR-TB patients, health professionals and the National TB programme (NTP) in Nepal. We conducted semi-structured interviews (SSIs) with 15 patients (10 men and 5 women, aged 21 to 68), four family members and three frontline health workers. In addition, three focus groups were held with MDR-TB patients and three with their family members. We conducted a series of meetings and workshops with key stakeholders to design the intervention, working closely with the NTP to enable government ownership. Our findings highlight the negative impacts of MDR-TB treatment on mental health, with greater impacts felt among those with limited social and financial support, predominantly married women. Michie et al's (2011) framework for behaviour change proved helpful in identifying corresponding practice- and policy-level changes. The findings from this study emphasise the need for tailored psycho-social support. Recent work on simple psychological support packages for the general population can usefully be adapted for use with people with MDR-TB.
耐多药结核病(MDR-TB)对全球公共卫生构成重大威胁,在低收入国家尤为如此。当前漫长(20个月)且艰巨的治疗方案使用的强效药物会产生包括精神健康问题在内的副作用。与药物敏感结核病患者相比,耐多药结核病患者的失访率很高(25%),病死率更高,治愈率更低。虽然一些国家结核病防治项目会为患者提供小额经济补贴,但心理社会健康问题的其他方面,包括医源性问题,并未得到常规评估或解决。我们旨在开发一种干预措施,以改善尼泊尔耐多药结核病患者的心理社会福祉。为此,我们与尼泊尔的耐多药结核病患者、卫生专业人员和国家结核病防治项目(NTP)开展了定性研究。我们对15名患者(10名男性和5名女性,年龄在21至68岁之间)、4名家庭成员和3名一线卫生工作者进行了半结构式访谈(SSIs)。此外,还与耐多药结核病患者举行了3次焦点小组讨论,与他们的家庭成员举行了3次焦点小组讨论。我们与关键利益相关者举行了一系列会议和研讨会来设计干预措施,并与国家结核病防治项目密切合作,以实现政府主导。我们的研究结果凸显了耐多药结核病治疗对心理健康的负面影响,社会和经济支持有限的人群,尤其是已婚女性,受到的影响更大。米基等人(2011年)的行为改变框架有助于确定相应的实践和政策层面的变化。这项研究的结果强调了提供量身定制的心理社会支持的必要性。最近针对普通人群的简单心理支持方案的研究成果可有效地改编用于耐多药结核病患者。